Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 937

1.

COSMOS-E: Guidance on conducting systematic reviews and meta-analyses of observational studies of etiology.

Dekkers OM, Vandenbroucke JP, Cevallos M, Renehan AG, Altman DG, Egger M.

PLoS Med. 2019 Feb 21;16(2):e1002742. doi: 10.1371/journal.pmed.1002742. eCollection 2019 Feb.

PMID:
30789892
2.

Core Outcome Set-STAndardised Protocol Items: the COS-STAP Statement.

Kirkham JJ, Gorst S, Altman DG, Blazeby JM, Clarke M, Tunis S, Williamson PR; COS-STAP Group.

Trials. 2019 Feb 11;20(1):116. doi: 10.1186/s13063-019-3230-x.

3.

A guide to systematic review and meta-analysis of prognostic factor studies.

Riley RD, Moons KGM, Snell KIE, Ensor J, Hooft L, Altman DG, Hayden J, Collins GS, Debray TPA.

BMJ. 2019 Jan 30;364:k4597. doi: 10.1136/bmj.k4597. No abstract available.

PMID:
30700442
4.

Bilateral versus Single Internal-Thoracic-Artery Grafts at 10 Years.

Taggart DP, Benedetto U, Gerry S, Altman DG, Gray AM, Lees B, Gaudino M, Zamvar V, Bochenek A, Buxton B, Choong C, Clark S, Deja M, Desai J, Hasan R, Jasinski M, O'Keefe P, Moraes F, Pepper J, Seevanayagam S, Sudarshan C, Trivedi U, Wos S, Puskas J, Flather M; Arterial Revascularization Trial Investigators.

N Engl J Med. 2019 Jan 31;380(5):437-446. doi: 10.1056/NEJMoa1808783.

PMID:
30699314
5.

CONSORT 2010 statement: extension checklist for reporting within person randomised trials.

Pandis N, Chung B, Scherer RW, Elbourne D, Altman DG.

Br J Dermatol. 2019 Jan 4. doi: 10.1111/bjd.17239. [Epub ahead of print]

PMID:
30609010
6.

Statistical methodology for constructing gestational age-related charts using cross-sectional and longitudinal data: The INTERGROWTH-21st project as a case study.

Ohuma EO, Altman DG; International Fetal and Newborn Growth Consortium for the 21st Century (INTERGROWTH-21st Project).

Stat Med. 2018 Nov 28. doi: 10.1002/sim.8018. [Epub ahead of print]

PMID:
30488491
7.

Development process of a consensus-driven CONSORT extension for randomised trials using an adaptive design.

Dimairo M, Coates E, Pallmann P, Todd S, Julious SA, Jaki T, Wason J, Mander AP, Weir CJ, Koenig F, Walton MK, Biggs K, Nicholl J, Hamasaki T, Proschan MA, Scott JA, Ando Y, Hind D, Altman DG.

BMC Med. 2018 Nov 16;16(1):210. doi: 10.1186/s12916-018-1196-2.

8.

A cross-sectional bibliometric study showed suboptimal journal endorsement rates of STROBE and its extensions.

Sharp MK, Tokalić R, Gómez G, Wager E, Altman DG, Hren D.

J Clin Epidemiol. 2018 Nov 10. pii: S0895-4356(18)30537-7. doi: 10.1016/j.jclinepi.2018.11.006. [Epub ahead of print]

9.

Overinterpretation and misreporting of prognostic factor studies in oncology: a systematic review.

Kempf E, de Beyer JA, Cook J, Holmes J, Mohammed S, Nguyên TL, Simera I, Trivella M, Altman DG, Hopewell S, Moons KGM, Porcher R, Reitsma JB, Sauerbrei W, Collins GS.

Br J Cancer. 2018 Nov;119(10):1288-1296. doi: 10.1038/s41416-018-0305-5. Epub 2018 Oct 24.

PMID:
30353050
10.

Design and other methodological considerations for the construction of human fetal and neonatal size and growth charts.

Ohuma EO, Altman DG.

Stat Med. 2018 Oct 23. doi: 10.1002/sim.8000. [Epub ahead of print]

PMID:
30352489
11.

Outcome reporting bias in trials: a methodological approach for assessment and adjustment in systematic reviews.

Kirkham JJ, Altman DG, Chan AW, Gamble C, Dwan KM, Williamson PR.

BMJ. 2018 Sep 28;362:k3802. doi: 10.1136/bmj.k3802. No abstract available.

12.

The STROBE Extensions: Considerations for Development.

Sharp MK, Hren D, Altman DG.

Epidemiology. 2018 Nov;29(6):e53-e56. doi: 10.1097/EDE.0000000000000899. No abstract available.

PMID:
30052544
13.

Poor reporting of multivariable prediction model studies: towards a targeted implementation strategy of the TRIPOD statement.

Heus P, Damen JAAG, Pajouheshnia R, Scholten RJPM, Reitsma JB, Collins GS, Altman DG, Moons KGM, Hooft L.

BMC Med. 2018 Jul 19;16(1):120. doi: 10.1186/s12916-018-1099-2.

14.

Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT.

Selby PJ, Banks RE, Gregory W, Hewison J, Rosenberg W, Altman DG, Deeks JJ, McCabe C, Parkes J, Sturgeon C, Thompson D, Twiddy M, Bestall J, Bedlington J, Hale T, Dinnes J, Jones M, Lewington A, Messenger MP, Napp V, Sitch A, Tanwar S, Vasudev NS, Baxter P, Bell S, Cairns DA, Calder N, Corrigan N, Del Galdo F, Heudtlass P, Hornigold N, Hulme C, Hutchinson M, Lippiatt C, Livingstone T, Longo R, Potton M, Roberts S, Sim S, Trainor S, Welberry Smith M, Neuberger J, Thorburn D, Richardson P, Christie J, Sheerin N, McKane W, Gibbs P, Edwards A, Soomro N, Adeyoju A, Stewart GD, Hrouda D.

Southampton (UK): NIHR Journals Library; 2018 Jun.

15.

Sample size for binary logistic prediction models: Beyond events per variable criteria.

van Smeden M, Moons KG, de Groot JA, Collins GS, Altman DG, Eijkemans MJ, Reitsma JB.

Stat Methods Med Res. 2018 Jan 1:962280218784726. doi: 10.1177/0962280218784726. [Epub ahead of print]

PMID:
29966490
16.

Some methodological issues in the design and analysis of cluster randomised trials.

Mansournia MA, Altman DG.

Br J Sports Med. 2018 Jun 14. pii: bjsports-2018-099628. doi: 10.1136/bjsports-2018-099628. [Epub ahead of print] No abstract available.

PMID:
29903855
17.

'Allocation concealment': the evolution and adoption of a methodological term.

Schulz KF, Chalmers I, Altman DG, Grimes DA, Moher D, Hayes RJ.

J R Soc Med. 2018 Jun;111(6):216-224. doi: 10.1177/0141076818776604. No abstract available.

PMID:
29877772
18.

Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration.

Sauerbrei W, Taube SE, McShane LM, Cavenagh MM, Altman DG.

J Natl Cancer Inst. 2018 Aug 1;110(8):803-811. doi: 10.1093/jnci/djy088.

19.

Reply to letter to the editor by C. Faggion: reproducibility and reporting guidelines.

Altman DG, Moher D.

J Clin Epidemiol. 2018 Aug;100:131-132. doi: 10.1016/j.jclinepi.2018.04.007. Epub 2018 Apr 13. No abstract available.

PMID:
29660480
20.

Avoiding bias in trials in which allocation ratio is varied.

Altman DG.

J R Soc Med. 2018 Apr;111(4):143-144. doi: 10.1177/0141076818764320. No abstract available.

PMID:
29648508
21.

SPIRIT promotes protocol sharing.

Chan AW, Moher D, Altman DG.

Lancet Psychiatry. 2018 May;5(5):390-391. doi: 10.1016/S2215-0366(18)30125-1. Epub 2018 Mar 29. No abstract available.

PMID:
29606566
22.

Incidence and clinical implications of intraoperative bilateral internal thoracic artery graft conversion: Insights from the Arterial Revascularization Trial.

Benedetto U, Altman DG, Flather M, Gerry S, Gray A, Lees B, Taggart DP; Arterial Revascularization Trial Investigators.

J Thorac Cardiovasc Surg. 2018 Jun;155(6):2346-2355.e6. doi: 10.1016/j.jtcvs.2018.02.012. Epub 2018 Feb 13.

PMID:
29559261
23.

Safety of Perioperative Aprotinin Administration During Isolated Coronary Artery Bypass Graft Surgery: Insights From the ART (Arterial Revascularization Trial).

Benedetto U, Altman DG, Gerry S, Gray A, Lees B, Angelini GD, Flather M, Taggart DP; ART (Arterial Revascularization Trial) Investigators.

J Am Heart Assoc. 2018 Mar 3;7(5). pii: e007570. doi: 10.1161/JAHA.117.007570.

24.

Population attributable fraction.

Mansournia MA, Altman DG.

BMJ. 2018 Feb 22;360:k757. doi: 10.1136/bmj.k757. No abstract available.

PMID:
29472187
25.

Reporting guidelines for oncology research: helping to maximise the impact of your research.

MacCarthy A, Kirtley S, de Beyer JA, Altman DG, Simera I.

Br J Cancer. 2018 Mar 6;118(5):619-628. doi: 10.1038/bjc.2017.407. Epub 2018 Feb 22. Review.

26.

Choosing important health outcomes for comparative effectiveness research: An updated systematic review and involvement of low and middle income countries.

Davis K, Gorst SL, Harman N, Smith V, Gargon E, Altman DG, Blazeby JM, Clarke M, Tunis S, Williamson PR.

PLoS One. 2018 Feb 13;13(2):e0190695. doi: 10.1371/journal.pone.0190695. eCollection 2018. Review.

27.

The INTERGROWTH-21st fetal growth standards: toward the global integration of pregnancy and pediatric care.

Papageorghiou AT, Kennedy SH, Salomon LJ, Altman DG, Ohuma EO, Stones W, Gravett MG, Barros FC, Victora C, Purwar M, Jaffer Y, Noble JA, Bertino E, Pang R, Cheikh Ismail L, Lambert A, Bhutta ZA, Villar J; International Fetal and Newborn Growth Consortium for the 21(st) Century (INTERGROWTH-21(st)).

Am J Obstet Gynecol. 2018 Feb;218(2S):S630-S640. doi: 10.1016/j.ajog.2018.01.011. Review.

PMID:
29422205
28.

Off-pump versus on-pump coronary artery bypass grafting: Insights from the Arterial Revascularization Trial.

Benedetto U, Altman DG, Gerry S, Gray A, Lees B, Flather M, Taggart DP; Arterial Revascularization Trial investigators.

J Thorac Cardiovasc Surg. 2018 Apr;155(4):1545-1553.e7. doi: 10.1016/j.jtcvs.2017.10.135. Epub 2017 Dec 23.

PMID:
29366570
29.

Assessing risk of bias in studies that evaluate health care interventions: recommendations in the misinformation age.

Page MJ, Boutron I, Hansen C, Altman DG, Hróbjartsson A.

J Clin Epidemiol. 2018 May;97:133-136. doi: 10.1016/j.jclinepi.2018.01.004. Epub 2018 Jan 17.

PMID:
29352995
30.

Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.

Copson ER, Maishman TC, Tapper WJ, Cutress RI, Greville-Heygate S, Altman DG, Eccles B, Gerty S, Durcan LT, Jones L, Evans DG, Thompson AM, Pharoah P, Easton DF, Dunning AM, Hanby A, Lakhani S, Eeles R, Gilbert FJ, Hamed H, Hodgson S, Simmonds P, Stanton L, Eccles DM.

Lancet Oncol. 2018 Feb;19(2):169-180. doi: 10.1016/S1470-2045(17)30891-4. Epub 2018 Jan 11.

31.

Influence of peer review on the reporting of primary outcome(s) and statistical analyses of randomised trials.

Hopewell S, Witt CM, Linde K, Icke K, Adedire O, Kirtley S, Altman DG.

Trials. 2018 Jan 11;19(1):30. doi: 10.1186/s13063-017-2395-4.

32.

Reply: An Incomplete Story.

Cleland JGF, Flather MD, Altman DG, Kotecha D; Beta-Blockers in Heart Failure Collaborative Group.

J Am Coll Cardiol. 2018 Jan 2;71(1):105. doi: 10.1016/j.jacc.2017.10.078. No abstract available.

33.

The satisfactory growth and development at 2 years of age of the INTERGROWTH-21st Fetal Growth Standards cohort support its appropriateness for constructing international standards.

Villar J, Cheikh Ismail L, Staines Urias E, Giuliani F, Ohuma EO, Victora CG, Papageorghiou AT, Altman DG, Garza C, Barros FC, Puglia F, Ochieng R, Jaffer YA, Noble JA, Bertino E, Purwar M, Pang R, Lambert A, Chumlea C, Stein A, Fernandes M, Bhutta ZA, Kennedy SH; International Fetal and Newborn Growth Consortium for the 21(st) Century (INTERGROWTH-21(st)).

Am J Obstet Gynecol. 2018 Feb;218(2S):S841-S854.e2. doi: 10.1016/j.ajog.2017.11.564. Epub 2017 Dec 20.

34.

Guidelines for the Content of Statistical Analysis Plans in Clinical Trials.

Gamble C, Krishan A, Stocken D, Lewis S, Juszczak E, Doré C, Williamson PR, Altman DG, Montgomery A, Lim P, Berlin J, Senn S, Day S, Barbachano Y, Loder E.

JAMA. 2017 Dec 19;318(23):2337-2343. doi: 10.1001/jama.2017.18556.

35.

Flaws in the application and interpretation of statistical analyses in systematic reviews of therapeutic interventions were common: a cross-sectional analysis.

Page MJ, Altman DG, McKenzie JE, Shamseer L, Ahmadzai N, Wolfe D, Yazdi F, Catalá-López F, Tricco AC, Moher D.

J Clin Epidemiol. 2018 Mar;95:7-18. doi: 10.1016/j.jclinepi.2017.11.022. Epub 2017 Dec 2.

PMID:
29203419
36.

Interventions to improve adherence to reporting guidelines in health research: a scoping review protocol.

Blanco D, Kirkham JJ, Altman DG, Moher D, Boutron I, Cobo E.

BMJ Open. 2017 Nov 16;7(11):e017551. doi: 10.1136/bmjopen-2017-017551. Review.

37.

Core Outcome Set-STAndards for Development: The COS-STAD recommendations.

Kirkham JJ, Davis K, Altman DG, Blazeby JM, Clarke M, Tunis S, Williamson PR.

PLoS Med. 2017 Nov 16;14(11):e1002447. doi: 10.1371/journal.pmed.1002447. eCollection 2017 Nov.

38.

Reproducible research practices are underused in systematic reviews of biomedical interventions.

Page MJ, Altman DG, Shamseer L, McKenzie JE, Ahmadzai N, Wolfe D, Yazdi F, Catalá-López F, Tricco AC, Moher D.

J Clin Epidemiol. 2018 Feb;94:8-18. doi: 10.1016/j.jclinepi.2017.10.017. Epub 2017 Nov 4. Review.

PMID:
29113936
39.

GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research.

Staniszewska S, Brett J, Simera I, Seers K, Mockford C, Goodlad S, Altman DG, Moher D, Barber R, Denegri S, Entwistle A, Littlejohns P, Morris C, Suleman R, Thomas V, Tysall C.

Res Involv Engagem. 2017 Aug 2;3:13. doi: 10.1186/s40900-017-0062-2. eCollection 2017.

40.

Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials.

Cleland JGF, Bunting KV, Flather MD, Altman DG, Holmes J, Coats AJS, Manzano L, McMurray JJV, Ruschitzka F, van Veldhuisen DJ, von Lueder TG, Böhm M, Andersson B, Kjekshus J, Packer M, Rigby AS, Rosano G, Wedel H, Hjalmarson Å, Wikstrand J, Kotecha D; Beta-blockers in Heart Failure Collaborative Group.

Eur Heart J. 2018 Jan 1;39(1):26-35. doi: 10.1093/eurheartj/ehx564.

41.

False Reassurance Based on Non-Significant Results.

Altman DG.

Clin Endosc. 2017 Nov;50(6):617. doi: 10.5946/ce.2017.091. Epub 2017 Aug 18. No abstract available.

42.

Statistics Notes: Percentage differences, symmetry, and natural logarithms.

Cole TJ, Altman DG.

BMJ. 2017 Aug 16;358:j3683. doi: 10.1136/bmj.j3683. No abstract available.

PMID:
28814563
43.

Statistics Notes: What is a percentage difference?

Cole TJ, Altman DG.

BMJ. 2017 Aug 16;358:j3663. doi: 10.1136/bmj.j3663. No abstract available.

PMID:
28814561
44.

GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research.

Staniszewska S, Brett J, Simera I, Seers K, Mockford C, Goodlad S, Altman DG, Moher D, Barber R, Denegri S, Entwistle A, Littlejohns P, Morris C, Suleman R, Thomas V, Tysall C.

BMJ. 2017 Aug 2;358:j3453. doi: 10.1136/bmj.j3453.

45.

Invited commentary: methodological issues in the design and analysis of randomised trials.

Mansournia MA, Altman DG.

Br J Sports Med. 2018 May;52(9):553-555. doi: 10.1136/bjsports-2017-098245. Epub 2017 Jul 29. No abstract available.

PMID:
28756393
46.

Enhancing the usability of systematic reviews by improving the consideration and description of interventions.

Hoffmann TC, Oxman AD, Ioannidis JP, Moher D, Lasserson TJ, Tovey DI, Stein K, Sutcliffe K, Ravaud P, Altman DG, Perera R, Glasziou P.

BMJ. 2017 Jul 20;358:j2998. doi: 10.1136/bmj.j2998. No abstract available.

PMID:
28729459
47.

Systematic review adherence to methodological or reporting quality.

Pussegoda K, Turner L, Garritty C, Mayhew A, Skidmore B, Stevens A, Boutron I, Sarkis-Onofre R, Bjerre LM, Hróbjartsson A, Altman DG, Moher D.

Syst Rev. 2017 Jul 19;6(1):131. doi: 10.1186/s13643-017-0527-2.

48.

Quality control of ultrasound for fetal biometry: results from the INTERGROWTH-21st Project.

Cavallaro A, Ash ST, Napolitano R, Wanyonyi S, Ohuma EO, Molloholli M, Sande J, Sarris I, Ioannou C, Norris T, Donadono V, Carvalho M, Purwar M, Barros FC, Jaffer YA, Bertino E, Pang R, Gravett MG, Salomon LJ, Noble JA, Altman DG, Papageorghiou AT.

Ultrasound Obstet Gynecol. 2018 Sep;52(3):332-339. doi: 10.1002/uog.18811. Epub 2018 Jul 26.

PMID:
28718938
49.

The COMET Handbook: version 1.0.

Williamson PR, Altman DG, Bagley H, Barnes KL, Blazeby JM, Brookes ST, Clarke M, Gargon E, Gorst S, Harman N, Kirkham JJ, McNair A, Prinsen CAC, Schmitt J, Terwee CB, Young B.

Trials. 2017 Jun 20;18(Suppl 3):280. doi: 10.1186/s13063-017-1978-4. Review.

50.

Support for reporting guidelines in surgical journals needs improvement: A systematic review.

Agha RA, Barai I, Rajmohan S, Lee S, Anwar MO, Fowler AJ, Orgill DP, Altman DG.

Int J Surg. 2017 Sep;45:14-17. doi: 10.1016/j.ijsu.2017.06.084. Epub 2017 Jun 30. Review.

PMID:
28673865

Supplemental Content

Loading ...
Support Center